199 related articles for article (PubMed ID: 33307801)
1. YAP activation in melanoma contributes to anoikis resistance and metastasis.
Zhao B; Xie J; Zhou X; Zhang L; Cheng X; Liang C
Exp Biol Med (Maywood); 2021 Apr; 246(8):888-896. PubMed ID: 33307801
[TBL] [Abstract][Full Text] [Related]
2. Pro-invasive activity of the Hippo pathway effectors YAP and TAZ in cutaneous melanoma.
Nallet-Staub F; Marsaud V; Li L; Gilbert C; Dodier S; Bataille V; Sudol M; Herlyn M; Mauviel A
J Invest Dermatol; 2014 Jan; 134(1):123-132. PubMed ID: 23897276
[TBL] [Abstract][Full Text] [Related]
3. Critical role of STAT3 in melanoma metastasis through anoikis resistance.
Fofaria NM; Srivastava SK
Oncotarget; 2014 Aug; 5(16):7051-64. PubMed ID: 25216522
[TBL] [Abstract][Full Text] [Related]
4. Tumor-Associated Endothelial Cells Promote Tumor Metastasis by Chaperoning Circulating Tumor Cells and Protecting Them from Anoikis.
Yadav A; Kumar B; Yu JG; Old M; Teknos TN; Kumar P
PLoS One; 2015; 10(10):e0141602. PubMed ID: 26509633
[TBL] [Abstract][Full Text] [Related]
5. Platelet‑derived growth factor‑BB mediates pancreatic cancer malignancy via regulation of the Hippo/Yes‑associated protein signaling pathway.
Li T; Guo T; Liu H; Jiang H; Wang Y
Oncol Rep; 2021 Jan; 45(1):83-94. PubMed ID: 33416116
[TBL] [Abstract][Full Text] [Related]
6. Mcl-1 is required for melanoma cell resistance to anoikis.
Boisvert-Adamo K; Longmate W; Abel EV; Aplin AE
Mol Cancer Res; 2009 Apr; 7(4):549-56. PubMed ID: 19372583
[TBL] [Abstract][Full Text] [Related]
7. The Hippo pathway oncoprotein YAP promotes melanoma cell invasion and spontaneous metastasis.
Zhang X; Yang L; Szeto P; Abali GK; Zhang Y; Kulkarni A; Amarasinghe K; Li J; Vergara IA; Molania R; Papenfuss AT; McLean C; Shackleton M; Harvey KF
Oncogene; 2020 Jul; 39(30):5267-5281. PubMed ID: 32561850
[TBL] [Abstract][Full Text] [Related]
8. STC1 competitively binding βPIX enhances melanoma progression via YAP nuclear translocation and M2 macrophage recruitment through the YAP/CCL2/VEGFA/AKT feedback loop.
Ren Z; Xu Z; Chang X; Liu J; Xiao W
Pharmacol Res; 2024 Jun; 204():107218. PubMed ID: 38768671
[TBL] [Abstract][Full Text] [Related]
9. Akt3-mediated resistance to apoptosis in B-RAF-targeted melanoma cells.
Shao Y; Aplin AE
Cancer Res; 2010 Aug; 70(16):6670-81. PubMed ID: 20647317
[TBL] [Abstract][Full Text] [Related]
10. Renieramycin M Sensitizes Anoikis-resistant H460 Lung Cancer Cells to Anoikis.
Sirimangkalakitti N; Chamni S; Suwanborirux K; Chanvorachote P
Anticancer Res; 2016 Apr; 36(4):1665-71. PubMed ID: 27069144
[TBL] [Abstract][Full Text] [Related]
11. An indispensable role of TAZ in anoikis resistance promoted by OTUB1 deubiquitinating enzyme in basal-like triple-negative breast cancer cells.
Nakagawa H; Higurashi M; Ishikawa F; Mori K; Shibanuma M
Biochem Biophys Res Commun; 2023 Mar; 649():1-9. PubMed ID: 36738577
[TBL] [Abstract][Full Text] [Related]
12. Timp1 interacts with beta-1 integrin and CD63 along melanoma genesis and confers anoikis resistance by activating PI3-K signaling pathway independently of Akt phosphorylation.
Toricelli M; Melo FH; Peres GB; Silva DC; Jasiulionis MG
Mol Cancer; 2013 Mar; 12():22. PubMed ID: 23522389
[TBL] [Abstract][Full Text] [Related]
13. ANKHD1 promotes proliferation and invasion of non‑small‑cell lung cancer cells via regulating YAP oncoprotein expression and inactivating the Hippo pathway.
Liu XF; Han Q; Rong XZ; Yang M; Han YC; Yu JH; Lin XY
Int J Oncol; 2020 May; 56(5):1175-1185. PubMed ID: 32319569
[TBL] [Abstract][Full Text] [Related]
14. Epithelial mesenchymal transition is required for acquisition of anoikis resistance and metastatic potential in adenoid cystic carcinoma.
Jia J; Zhang W; Liu JY; Chen G; Liu H; Zhong HY; Liu B; Cai Y; Zhang JL; Zhao YF
PLoS One; 2012; 7(12):e51549. PubMed ID: 23272116
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-200a promotes anoikis resistance and metastasis by targeting YAP1 in human breast cancer.
Yu SJ; Hu JY; Kuang XY; Luo JM; Hou YF; Di GH; Wu J; Shen ZZ; Song HY; Shao ZM
Clin Cancer Res; 2013 Mar; 19(6):1389-99. PubMed ID: 23340296
[TBL] [Abstract][Full Text] [Related]
16. Histone deacetylase inhibitors restore toxic BH3 domain protein expression in anoikis-resistant mammary and brain cancer stem cells, thereby enhancing the response to anti-ERBB1/ERBB2 therapy.
Cruickshanks N; Hamed HA; Booth L; Tavallai S; Syed J; Sajithlal GB; Grant S; Poklepovic A; Dent P
Cancer Biol Ther; 2013 Oct; 14(10):982-96. PubMed ID: 24025251
[TBL] [Abstract][Full Text] [Related]
17. Imperatorin sensitizes anoikis and inhibits anchorage-independent growth of lung cancer cells.
Choochuay K; Chunhacha P; Pongrakhananon V; Luechapudiporn R; Chanvorachote P
J Nat Med; 2013 Jul; 67(3):599-606. PubMed ID: 23108812
[TBL] [Abstract][Full Text] [Related]
18. SRC tyrosine kinase activates the YAP/TAZ axis and thereby drives tumor growth and metastasis.
Lamar JM; Xiao Y; Norton E; Jiang ZG; Gerhard GM; Kooner S; Warren JSA; Hynes RO
J Biol Chem; 2019 Feb; 294(7):2302-2317. PubMed ID: 30559289
[TBL] [Abstract][Full Text] [Related]
19. STAT3 induces anoikis resistance, promotes cell invasion and metastatic potential in pancreatic cancer cells.
Fofaria NM; Srivastava SK
Carcinogenesis; 2015 Jan; 36(1):142-50. PubMed ID: 25411359
[TBL] [Abstract][Full Text] [Related]
20. ATF4-dependent induction of heme oxygenase 1 prevents anoikis and promotes metastasis.
Dey S; Sayers CM; Verginadis II; Lehman SL; Cheng Y; Cerniglia GJ; Tuttle SW; Feldman MD; Zhang PJ; Fuchs SY; Diehl JA; Koumenis C
J Clin Invest; 2015 Jul; 125(7):2592-608. PubMed ID: 26011642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
